Background and Purpose— Evidence from the real-world setting complements evidence
coming from randomized controlled trials. We aimed to summarize all available evidence from …

… This study confirmed the effectiveness and safety of non-vitamin K antagonist oral anticoagulants
for the treatment of non-valvular atrial fibrillation in real-world settings, consistent with …

Full article: Comparison of major bleeding risk in patients with non-valvular atrial fibrillation
receiving direct oral anticoagulants in the real-world setting: a network meta-analysis Skip to …

… anticoagulant drugs. To facilitate a direct comparison between new users of direct oral
anticoagulants … were excluded if they had any anticoagulant prescription in the last 12 months …

… Oral anticoagulants such as apixaban, dabigatran, and … indirect comparison meta-analysis
between new oral agents … parameters may exist between oral anticoagulant agents in patients …

… Different from warfarin, novel oral anticoagulants (NOACs) … Although direct or indirect
comparisons between NOACs have … the most favourable oral anticoagulation for Asian patients. …

… Reasons behind the better persistence with warfarin or apixaban compared to rivaroxaban
or dabigatran treatment in our real-life setting are not known but differences in tolerability may …

… a range of representative care settings in each participating … of the different care settings in
each participating country (office-… with DTI and FXaI in comparison with VKAs are consistent …

… Small portable devices have enabled patient self-monitoring of anticoagulation and self-…
of oral anticoagulant therapy with conventional management by a specialist anticoagulation …

… Although direct comparisons among agents cannot be made, given the lack of a randomized
clinical trial comparing the 3 agents, there are some key differences in the design and the …